ProtoKinetix, Inc.
PKTXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for PKTX. That does not mean none is planned.
Get an email about PKTX's next catalysts
Track ProtoKinetix (PKTX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
Artemether Sublingual Spray
Plasmodium Falciparum Malaria
Quinine
Falciparum Malaria
Artemether
Falciparum Malaria
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Artemether Sublingual Spray | Phase 3 | Plasmodium Falciparum Malaria | - | - |
Quinine | Phase 2 | Falciparum Malaria | - | - |
Artemether | Phase 2 | Falciparum Malaria | - | - |
Frequently asked questions
What is in ProtoKinetix, Inc.'s drug pipeline?β
CatalystAlert tracks 3 drug candidates in ProtoKinetix, Inc.'s (PKTX) pipeline across Phase 3, Phase 2. Its lead program is Artemether Sublingual Spray (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ProtoKinetix, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for ProtoKinetix, Inc. (PKTX) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track PKTX biotech catalysts?β
Add PKTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ProtoKinetix, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
